Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 8/20 | 0.66 |
| ▸ | MTNR1B | P49286 | 8/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | TSHR | P16473 | 1/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.66 |
| ▸ | GRM7 | Q14831 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | FASN | P49327 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9731531 | 0.88 | MTNR1A (0.53) | MTNR1AMTNR1BCYP1A2ALOX15MEN1 | |
| SCHEMBL55304 | 0.87 | MTNR1A (0.49) | MTNR1AMTNR1BCYP1A2ALOX15MEN1 | |
| SCHEMBL9731502 | 0.81 | MTNR1A (0.56) | MTNR1AMTNR1BCYP1A2ALOX15MEN1 | |
| SCHEMBL29759505 | 0.80 | MTNR1A (1.00) | MTNR1AMTNR1BCYP1A2ALOX15MEN1 | |
| SCHEMBL3070126 | 0.80 | MTNR1A (1.00) | MTNR1AMTNR1BCYP1A2ALOX15MEN1 | |
| SCHEMBL54783 | 0.80 | MTNR1A (1.00) | MTNR1AMTNR1BCYP1A2ALOX15MEN1 | |
| SCHEMBL3070121 | 0.80 | MTNR1A (1.00) | MTNR1AMTNR1BCYP1A2ALOX15MEN1 | |
| SCHEMBL6359193 | 0.76 | MTNR1A (0.79) | MTNR1AMTNR1BCYP1A2ALOX15MEN1 | |
| SCHEMBL9731623 | 0.74 | MAPT (0.43) | MTNR1AMTNR1BCYP1A2ALOX15MEN1 | |
| SCHEMBL28453641 | 0.72 | OPRM1 (0.44) | SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5071875-A | Nervous system, psychological disorders; sleep cycle, skin dis coloration | NORTHWESTERN UNIVERSITY (US) | 1991-12-10 | — | — | US | claimed |
| EP-0420064-A2 | Substituted 2-amidotetralins as melatonin agonists and antagonists | NORTHWESTERN UNIVERSITY (US) | 1991-04-03 | — | — | EP | claimed |
| EP-2120912-B1 | METHODS OF CORRECTING IMBALANCE BETWEEN BONE RESORPTION AND BONE FORMATION AND KITS AND COMPOSITIONS THEREFOR | CHU SAINTE JUSTINE (CA) | 2013-04-03 | — | — | EP | disclosed |
| US-8222298-B2 | Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor | CHU SAINTE-JUSTINE (CA) | 2012-07-17 | — | — | US | disclosed |
| US-20120135930-A1 | METHODS OF CORRECTING IMBALANCE BETWEEN BONE RESORPTION AND BONE FORMATION AND KITS AND COMPOSITIONS THEREFOR | CHU SAINTE-JUSTINE | 2012-05-31 | — | — | US | disclosed |
| US-8129432-B2 | Method of correcting imbalance between bone resorption and bone formation and kits and compositions therefor | CHU SAINTE-JUSTINE (CA) | 2012-03-06 | — | — | US | disclosed |
| US-20100029567-A1 | METHOD OF CORRECTING IMBALANCE BETWEEN BONE RESORPTION AND BONE FORMATION AND KITS AND COMPOSITIONS THEREFOR | CHU SAINTE-JUSTINE (CA) | 2010-02-04 | — | — | US | disclosed |
| EP-2120912-A1 | METHODS OF CORRECTING IMBALANCE BETWEEN BONE RESORPTION AND BONE FORMATION AND KITS AND COMPOSITIONS THEREFOR | Chu Sainte-justine (CA) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008098379-A1 | METHODS OF CORRECTING IMBALANCE BETWEEN BONE RESORPTION AND BONE FORMATION AND KITS AND COMPOSITIONS THEREFOR | CHU SAINTE-JUSTINE (CA) | 2008-08-21 | — | — | WO | disclosed |
| US-5151446-A | Neurological disorders or cardiovascular disorders | NORTHWESTERN UNIVERSITY (US) | 1992-09-29 | — | — | US | disclosed |
| US-5071875-A | Nervous system, psychological disorders; sleep cycle, skin dis coloration | NORTHWESTERN UNIVERSITY (US) | 1991-12-10 | — | — | US | disclosed |
| EP-0420064-A2 | Substituted 2-amidotetralins as melatonin agonists and antagonists | NORTHWESTERN UNIVERSITY (US) | 1991-04-03 | — | — | EP | disclosed |